The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Angiotensin receptors: a new role in cancer?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Fujiyama, S., Matsubara, H., Nozawa, Y., Maruyama, K., Mori, Y., Tsutsumi, Y., Masaki, H., Uchiyama, Y., Koyama, Y., Nose, A., et al. (2001) · Circulation Research · doi:10.1161/01.res.88.1.22 · Cited by 202
RetractedInflammation and angiotensin II
Suzuki, Y., Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Esteban, V., & Egido, J. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00271-6 · Cited by 694
Vascular inflammation and the renin-angiotensin system
Brasier, A. R., Recinos, A., & Eledrisi, M. S. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000021412.56621.a2 · Cited by 586
Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?
Lever, A. F., Hole, D. J., Gillis, C. R., McCallum, I. R., McInnes, G. T., MacKinnon, P. L., Meredith, P. A., Murray, L. S., Reid, J. L., & Robertson, J. W. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03228-0 · Cited by 545
Pueyo, M. E., Gonzalez, W., Nicoletti, A., Savoie, F., Arnal, J.-F., & Michel, J.-B. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.3.645 · Cited by 517
Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth
Egami, K., Murohara, T., Shimada, T., Sasaki, K.-I., Shintani, S., Sugaya, T., Ishii, M., Akagi, T., Ikeda, H., Matsuishi, T., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16645 · Cited by 345
Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats.
Volpert, O. V., Ward, W. F., Lingen, M. W., Chesler, L., Solt, D. B., Johnson, M. D., Molteni, A., Polverini, P. J., & Bouck, N. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118838 · Cited by 323
Suganuma, T., Ino, K., Shibata, K., Kajiyama, H., Nagasaka, T., Mizutani, S., & Kikkawa, F. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1946 · Cited by 237
Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis
Fujita, M., Hayashi, I., Yamashina, S., Itoman, M., & Majima, M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00496-5 · Cited by 233
Angiotensin II and the Endothelium: Diverse Signals and Effects
Watanabe, T., Barker, T. A., & Berk, B. C. (2005) · Hypertension · doi:10.1161/01.hyp.0000153321.13792.b9 · Cited by 227
The function of the protein tyrosine phosphatase SHP-1 in cancer
Wu, C. (2003) · Gene · doi:10.1016/s0378-1119(03)00400-1 · Cited by 225
Signal Transduction from the Angiotensin II AT2 Receptor
Nouet, S., & Nahmias, C. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(99)00205-2 · Cited by 213
Self-citationNouet, S., Amzallag, N., Li, J.-M., Louis, S., Seitz, I., Cui, T.-X., Alleaume, A.-M., Di Benedetto, M., Boden, C., Masson, M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403880200 · Cited by 189
Self-citationUemura, H., Ishiguro, H., Nakaigawa, N., Nagashima, Y., Miyoshi, Y., Fujinami, K., Sakaguchi, A., & Kubota, Y. (2003) · PubMed · Cited by 188
Direct evidence of leukocyte adhesion in arterioles by angiotensin II
Álvarez, A., Cerdá-Nicolás, M., Naim Abu Nabah, Y., Mata, M., Issekutz, A. C., Panés, J., Lobb, R. R., & Sanz, M.-J. (2004) · Blood · doi:10.1182/blood-2003-08-2974 · Cited by 181
Bekay, R. E., Álvarez, M., Monteseirín, J., Álba, G., Chacón, P., Vega, A. P., Martín‐Nieto, J., Jiménez, J., Pintado, E., Bedoya, F. J., et al. (2003) · Blood · doi:10.1182/blood-2002-09-2785 · Cited by 170
Inhibition of human lung cancer cell growth by angiotensin-(1-7)
Gallagher, P. E. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh236 · Cited by 165
Fujita, M., Hayashi, I., Yamashina, S., Fukamizu, A., Itoman, M., & Majima, M. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh324 · Cited by 165
Miyajima, A., Kosaka, T., Asano, T., Asano, T., Seta, K., Kawai, T., & Hayakawa, M. (2002) · PubMed · Cited by 158
Angiotensin-converting enzyme inhibitors and the risk of cancer
Friis, S., Sørensen, H. T., Mellemkjøer, L., McLaughlin, J. K., Nielsen, G. L., Blot, W. J., & Olsen, J. H. (2001) · Cancer · Cited by 153
Koh, W., Yuan, J., Sun, C., Berg, D. V. D., Seow, A., Lee, H.-P., & Yu, M. C. (2003) · PubMed · Cited by 153
AT 2 Receptor-Mediated Relaxation Is Preserved After Long-Term AT 1 Receptor Blockade
Widdop, R. E., Matrougui, K., Levy, B. I., & Henrion, D. (2002) · Hypertension · doi:10.1161/01.hyp.0000033224.99806.8a · Cited by 153
Fujimoto, Y., Sasaki, T., Tsuchida, A., & Chayama, K. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02377-8 · Cited by 147
Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma
Juillerat‐Jeanneret, L., Célérier, J., Bernasconi, C. C., Nguyen, G., Wostl, W., Maerki, H. P., Janzer, R.-C., Corvol, P. L., & Gasc, J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601646 · Cited by 146
Regulation of Transport of the Angiotensin AT2 Receptor by a Novel Membrane-Associated Golgi Protein
Wruck, C. J., Funke‐Kaiser, H., Pufe, T., Kusserow, H., Menk, M., Schefe, J. H., Kruse, M. L., Stoll, M., & Unger, T. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000150662.51436.14 · Cited by 145
Differential regulation of in vivo angiogenesis by angiotensin II receptors
Walther, T., Menrad, A., Orzechowski, H., Siemeister, G., Paul, M., & Schirner, M. (2003) · The FASEB Journal · doi:10.1096/fj.03-0129com · Cited by 138
Greco, S., Muscella, A., Elia, M. G., Salvatore, P., Storelli, C., Mazzotta, A., Manca, C., & Marsigliante, S. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10313 · Cited by 131
Li, C. I., Malone, K. E., Weiss, N. S., Boudreau, D. M., Cushing‐Haugen, K. L., & Daling, J. R. (2003) · Cancer · doi:10.1002/cncr.11663 · Cited by 130
Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma
Hii, S.-I., Nicol, D. L., Gotley, D. C., Thompson, L. C., Green, M. K., & Jonsson, J. R. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.145 · Cited by 129
Benndorf, R. A., Böger, R. H., Ergün, S., Steenpaß, A., & Wieland, T. (2003) · Circulation Research · doi:10.1161/01.res.0000088358.99466.04 · Cited by 123
Imanishi, T., Hano, T., & Nishio, I. (2004) · Hypertension Research · doi:10.1291/hypres.27.101 · Cited by 120
Arrieta, O. G., Guevara, P., Escobar, E., García-Navarrete, R., Pineda, B., & Sotelo, J. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602483 · Cited by 120
Identification of a new tumor suppressor gene located at chromosome 8p21.3–22
Seibold, S., Rudroff, C., Weber, M. F. A., Galle, J., Wanner, C., & Marx, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0934fje · Cited by 115
Involvement of chymase-mediated angiotensin II generation in blood pressure regulation
Li, M., Liu, K., Michalicek, J., Angus, J. A., Hunt, J. E., Dell’Italia, L. J., Feneley, M. P., Graham, R. M., & Husain, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20805 · Cited by 114
Silvestre, J., Tamarat, R., Senbonmatsu, T., Icchiki, T., Ebrahimian, T. G., Iglarz, M., Besnard, S., Duriez, M., Inagami, T., & Levy, B. I. (2002) · Circulation Research · doi:10.1161/01.res.0000019892.41157.24 · Cited by 108
Angiotensin II Induces Migration and Pyk2/Paxillin Phosphorylation of Human Monocytes
Kintscher, U., Wakino, S., Kim, S., Fleck, E., Hsueh, W. A., & Law, R. E. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.587 · Cited by 105
Otani, A., Takagi, H., Oh, H., Koyama, S., & Honda, Y. (2001) · Diabetes · doi:10.2337/diabetes.50.4.867 · Cited by 105
Lindholm, L. H., Anderson, H., Ekbom, T., Hansson, L., Lanke, J., Dahlöf, B., Fairé, U. D., Forsén, K., Hedner, T., Linjer, E., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05704-x · Cited by 105
Ohashi, H., Takagi, H., Oh, H., Suzuma, K., Suzuma, I., Miyamoto, N., Uemura, A., Watanabe, D., Murakami, T., Sugaya, T., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000121103.03275.ec · Cited by 96
Röcken, C., Lendeckel, U., Dierkes, J., Westphal, S., Carl‐McGrath, S., Peters, B., Krüger, S., Malfertheiner, P., Roessner, A., & Ebert, M. P. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1922 · Cited by 93
Yasumatsu, R., Nakashima, T., Masuda, M., Ito, A., Kuratomi, Y., Nakagawa, T., & Komune, S. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0582-7 · Cited by 87
武田, 光., & Kondo, S. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64119-3 · Cited by 86
Rizkalla, B., Forbes, J. M., Cooper, M. E., & Cao, Z. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000099374.58607.c9 · Cited by 86
Paepe, B. D., Verstraeten, V. L. R. M., Potter, C. R. D., Vakaet, L., & Bullock, G. (2001) · Histochemistry and Cell Biology · doi:10.1007/s004180100313 · Cited by 84
Zhang, X., Lassila, M., Cooper, M. E., & Cao, Z. (2004) · Hypertension · doi:10.1161/01.hyp.0000113628.94574.0f · Cited by 84
Medeiros, R., Vasconcelos, A., Costa, S., Pinto, D., Lobo, F., Morais, A., Oliveira, J., & Lopes, C. (2004) · The Journal of Pathology · doi:10.1002/path.1529 · Cited by 82
Haiman, C. A., Henderson, S. O., Bretsky, P. M., Kolonel, L. N., & Henderson, B. E. (2003) · PubMed · Cited by 79
Angiotensin converting enzyme inhibitors for cancer treatment?
Nielsen, D. L., Jensen, B. V., Eriksen, J., Skovsgaard, T., & Lindberg, H. (2004) · Acta Oncologica · doi:10.1080/02841860310022346 · Cited by 77
Wu, L., Iwai, M., Li, Z., Shiuchi, T., Min, L., Cui, T., Li, J., Okumura, M., Nahmias, C., & Horiuchi, M. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0053 · Cited by 75
Self-citationPaepe, B. D., Verstraeten, V. L. R. M., Potter, C. R. D., & Bullock, G. (2001) · Histochemistry and Cell Biology · doi:10.1007/s00418-001-0356-0 · Cited by 69
Koh, W.-P., Yuan, J.-M., Berg, D. V. D., Lee, H.-P., & Yu, M. C. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh309 · Cited by 64
Dinh, D. T., Frauman, A. G., Sourial, M., CASLEY, D. J., Johnston, C. I., & Fabiani, M. E. (2001) · Endocrinology · doi:10.1210/endo.142.3.8020 · Cited by 57
Activation of invasiveness of cervical carcinoma cells by angiotensin II
Kikkawa, F., Mizuno, M., Shibata, K., Kajiyama, H., Morita, T., Ino, K., Nomura, S., & Mizutani, S. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2003.12.013 · Cited by 53
Freitas-Silva, M., Pereira, D., Coelho, C., Bicho, M., Lopes, C., & Medeiros, R. (2004) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2004.03.020 · Cited by 52
Knowle, D., Ahmed, S. T., & Pulakat, L. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(99)00111-1 · Cited by 37
Takagi, T. (2002) · Carcinogenesis · doi:10.1093/carcin/23.7.1235 · Cited by 26
Cited by
Extracellular matrix and its therapeutic potential for cancer treatment
Huang, J., Zhang, L., Wan, D., Zhou, L., Zheng, S., Lin, S., & Qiao, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00544-0 · Cited by 962
Diop-Frimpong, B., Chauhan, V. P., Krane, S., Boucher, Y., & Jain, R. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018892108 · Cited by 733
Inflammation and EMT: an alliance towards organ fibrosis and cancer progression
López‐Novoa, J. M., & Nieto, M. A. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900043 · Cited by 654
Hunyady, L., & Catt, K. J. (2006) · Molecular Endocrinology · doi:10.1210/me.2004-0536 · Cited by 541
The renin–angiotensin system and cancer: old dog, new tricks
George, A. J., Thomas, W. G., & Hannan, R. D. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2945 · Cited by 525
Metadata
- Authors
- Deshayes, F., & Nahmias, C.
- Venue
- Trends in Endocrinology & Metabolism
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 16
- Issue
- 7
- Pages
- 293-299
- ISSN
- 1043-2760 (ISSN-L)
- OpenAlex
- W2082943727
- Cited by
- 437
- References
- 56
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.